1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Analytical Instrument Sales

  1. Agilent

    Anonymous board for Agilent
    Discussions:
    1
    Messages:
    5
    RSS
  2. Beckman Coulter

    Anonymous board for Beckman Coulter
    Discussions:
    2
    Messages:
    14
    RSS
  3. PerkinElmer

    Anonymous board for PerkinElmer
    Discussions:
    2
    Messages:
    19
    RSS
  4. Sciex

    Anonymous board for Sciex
    Discussions:
    0
    Messages:
    0
    (Contains no messages)
    RSS
  5. Shimadzu

    Anonymous board for Shimadzu
    Discussions:
    0
    Messages:
    0
    (Contains no messages)
    RSS
  6. Thermo Scientific

    Anonymous board for Thermo Scientific
    Discussions:
    8
    Messages:
    22
    RSS
  7. Varian

    Anonymous board for Varian
    Discussions:
    0
    Messages:
    0
    (Contains no messages)
    RSS
  8. Waters

    Anonymous board for Waters
    Discussions:
    3
    Messages:
    17
    RSS